ID
15674
Description
Nerventra Study (Eudra CT 2007-003226-19) Study MS-LAQ-301: A multinational, multicenter, randomized, double-blind, parallel-group, placebo-controlled study, to evaluate the safety, tolerability and efficacy of daily oral administration of laquinimod 0.6 mg in subjects with relapsing remitting multiple sclerosis (RRMS)
Keywords
Versions (1)
- 6/8/16 6/8/16 -
Uploaded on
June 8, 2016
DOI
To request one please log in.
License
Creative Commons BY-NC 3.0
Model comments :
You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.
Itemgroup comments for :
Item comments for :
In order to download data models you must be logged in. Please log in or register for free.
Nerventra Study Visit 6
Nerventra Study Visit 6
- StudyEvent: ODM
Description
Repeated MRI Scan Performance Visit 6
Description
date MRI
Data type
date
Alias
- UMLS CUI [1,1]
- C0011008
- UMLS CUI [1,2]
- C0024485
Description
MRI
Data type
boolean
Alias
- UMLS CUI [1]
- C0024485
Description
Contrast agent
Data type
integer
Alias
- UMLS CUI [1]
- C0009924
Description
Contrast agent
Data type
text
Alias
- UMLS CUI [1]
- C0009924
Description
MRI performed
Data type
boolean
Alias
- UMLS CUI [1]
- C0024485
Description
MRI
Data type
text
Alias
- UMLS CUI [1]
- C0024485
Description
Findings
Data type
boolean
Alias
- UMLS CUI [1]
- C0243095
Description
If an adverse event occurs during the MRI performance, please inform the investigator in order to record on adverse event log
Data type
text
Alias
- UMLS CUI [1]
- C0243095
Similar models
Nerventra Study Visit 6
- StudyEvent: ODM
C0600091 (UMLS CUI [1,2])
C0024485 (UMLS CUI [1,2])